CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease
In-Jeong Cho, Seok-Min Kang
Kidney Res Clin Pract. 2021;40(4):555-565.   Published online November 22, 2021
DOI: https://doi.org/10.23876/j.krcp.21.900

Excel Download

Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease
Kidney Research and Clinical Practice. 2021;40(4):555-565   Crossref logo
Link1 Link2 Link3

Real world experience on angiotensin receptor and neprilysin inhibition in reduced ejection fraction heart failure patients with advanced chronic kidney disease
European Heart Journal. 2020;41(Supplement_2):   Crossref logo
Link1 Link2

The Effctiveness Of Angiotensin Receptor Neprilysin Inhibitor On Improving The Cardiac Remodelling Compared To Ace-Inhibitor On Patients With Chronic Heart Failure
Indonesian Journal of Pharmaceutical and Clinical Research. 2021;4(1):15-25   Crossref logo
Link1 Link2

Angiotensin receptor/neprilysin inhibitor—a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings
Heart Failure Reviews. 2019;25(3):393-402   Crossref logo
Link1 Link2 Link3

Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime
ESC Heart Failure. 2022;9(5):3639-3642   Crossref logo
Link1 Link2 Link3

Impact of angiotensin-receptor neprilysin inhibitor on reverse cardiac remodeling in patients with heart failure with reduced ejection fraction (hfref)
European Heart Journal. 2022;43(Supplement_1):   Crossref logo
Link1 Link2

Could angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor–neprilysin inhibitor be used in heart failure patients with atrial fibrillation and low blood pressure? Letter regarding the article ‘Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology’
European Journal of Heart Failure. 2022;24(6):1142-1142   Crossref logo
Link1 Link2 Link3

Angiotensin Receptor Neprilysin Inhibitor Therapy Improves Ejection Fraction in Patients with Systolic Heart Failure
Journal of Cardiac Failure. 2018;24(8):S53   Crossref logo
Link1 Link2

LCZ696, an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure and hypertension
BMC Pharmacology. 2011;11(S1):   Crossref logo
Link1 Link2 Link3

Impact of ARNI (angiotensin receptor neprilysin inhibitor) on functional status of patients with heart failure and reduced ejection fraction (HFREF)
Journal of the Saudi Heart Association. 2018;30(4):358   Crossref logo
Link1 Link2 Link3